Free Trial
→ Trump’s secret China deal (From Porter & Company) (Ad)tc pixel Free CSLLY Stock Alerts

CSL (CSLLY) Stock Forecast & Price Target

CSL logo
$19.06 -0.08 (-0.42%)
As of 06/12/2026 03:58 PM Eastern
Compare

CSL - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Reduce
Based on 5 Analyst Ratings
Sell
1
Hold
4
Buy
0

Based on 5 Wall Street analysts who have issued ratings for CSL in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 5 analysts, 1 has given a sell rating, and 4 have given a hold rating for CSLLY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CSLLY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CSL and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CSLLY Analyst Ratings Over Time

TypeCurrent Forecast
6/14/25 to 6/14/26		1 Month Ago
5/15/25 to 5/15/26		3 Months Ago
3/16/25 to 3/16/26		1 Year Ago
6/14/24 to 6/14/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
2 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
4 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingReduceReduceModerate BuyStrong Buy

CSLLY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CSLLY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CSL Stock vs. The Competition

TypeCSLMedical CompaniesBroader Market
Consensus Rating Score
1.80
2.29
2.52
Consensus RatingReduceHoldModerate Buy
Predicted UpsideN/A695.37% Upside13.95% Upside
News Sentiment Rating
Negative News

See Recent CSLLY News
Positive News
Positive News
Export
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
5/29/2026
Jefferies Financial Group Inc. logo
Jefferies Financial Group
2 of 5 stars
 DowngradeStrong-Buy ➝ Hold
5/11/2026
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
4 of 5 stars
 DowngradeStrong-Buy ➝ Hold
5/11/2026
Zacks Research logo
Zacks Research
Not Rated
 DowngradeHold ➝ Strong Sell
5/11/2026
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeStrong-Buy ➝ Hold
2/11/2026
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeModerate Buy ➝ Hold
1/16/2025
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
D. Thillainathan
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
UpgradeStrong-Buy
8/13/2024
Macquarie Infrastructure Holdings, LLC logo
Macquarie Infrastructure
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
D. Bailey
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
UpgradeStrong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 04:23 PM ET.


Should I Buy CSL Stock? CSLLY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, June 8, 2026. Please send any questions or comments about these CSL pros and cons to contact@marketbeat.com.

CSL
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in CSL Limited:

  • CSL Limited has a strong presence in the biopharmaceutical industry, focusing on innovative therapies and vaccines, which positions it well for future growth.
  • The company recently reached a new 52-week low stock price of approximately $18.14, which may present a buying opportunity for investors looking for value.
  • CSL Limited operates through multiple segments, including CSL Behring and CSL Seqirus, diversifying its revenue streams and reducing reliance on any single product line.
  • With a debt-to-equity ratio of 0.51, CSL Limited maintains a healthy balance sheet, indicating lower financial risk and the ability to invest in growth opportunities.
  • Analysts have a consensus rating of "Moderate Buy" for CSL Limited, suggesting that there is positive sentiment about the company's future performance.

CSL
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in CSL Limited for these reasons:

  • The stock has experienced significant volatility, recently trading down from a previous close of $21.81, which may indicate underlying challenges.
  • Royal Bank of Canada downgraded CSL Limited from a "moderate buy" to a "hold" rating, reflecting concerns about its short-term performance.
  • CSL Limited's 50-day simple moving average is around $25.99, suggesting that the stock has been underperforming relative to its recent price trends.
  • Market analysts have noted that the company faces increasing competition in the biopharmaceutical sector, which could impact its market share and profitability.
  • Investors may be cautious due to the company's reliance on specific therapeutic areas, such as iron deficiency and nephrology, which could be subject to regulatory changes and market fluctuations.

CSLLY Forecast - Frequently Asked Questions

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CSL in the last twelve months. There is currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" CSLLY shares.

According to analysts, CSL's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, CSL's stock had 4 downgrades by analysts.

CSL has been rated by research analysts at Canaccord Genuity Group, Citigroup, Jefferies Financial Group, and Zacks Research in the past 90 days.

Analysts like CSL less than other "medical" companies. The consensus rating for CSL is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how CSLLY compares to other companies.

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With CSL Recommendations


This page (OTCMKTS:CSLLY) was last updated on 6/14/2026 by MarketBeat.com Staff.
From Our Partners
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
This Could Be the Biggest Monetary Shift in 50 Years
Tucked inside U.S. Code Title 31, Section 5117 is a provision allowing the Treasury to reprice America's gold ...
Americas Gold Company | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
There’s a new type of capitalism
The U.S. government has taken direct equity positions in at least 10 companies - Intel, U.S. Steel, Westinghou...
Porter & Company | Sponsoredtc pixel
80X Growth in ONE Quarter (Read before June 16)
Marc Chaikin - creator of one of Wall Street's most widely used indicators - is sounding the alarm on a pre-IP...
Chaikin Analytics | Sponsoredtc pixel